Answers are grounded in this paper and cite their sources.
INTRODUCTION Apolipoprotein E ( APOE ) ε4 's effect on Alzheimer's disease (AD) depends on ancestry and environmental risk factors. The APOE ε4 –AD link in American Indian (AI) populations appears attenuated, with current understanding largely informed by a single research study. This study seeks to extend this evidence in an AI population in Minnesota. METHODS Cross‐sectional analysis of APOE ε4 , medical comorbidities, and AD plasma biomarkers with 182 tribal elders. RESULTS Median age was 67; 70% were female; median Mini‐Mental State Examination score was 29. Age‐, sex‐, and chronic kidney disease‐adjusted log odds ratios with 95% confidence intervals for APOE ε4 carrier status on amyloid beta 42/40, tau phosphorylated at threonine 217 (p‐tau217), and glial fibrillary acidic protein (GFAP) were 0.86 (0.80 to 0.94), 1.04 (0.87 to 1.25), and 1.00 (0.86 to 1.16). CONCLUSION Compared to non‐Hispanic White populations, APOE ε4 has an attenuated effect on p‐tau217 or GFAP in AI tribal elders. Limitations of this study include survival bias and race‐associated differences in social determinants of health that can influence the observed results.
No takes yet. Share an insight, caveat, or question.
Matheson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: